-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – B-4T2001 in Metastatic Pancreatic Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - B-4T2001 in Metastatic Pancreatic Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. B-4T2001 in Metastatic Pancreatic Cancer Drug Details: B4T2-001 is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – B-4T2001 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - B-4T2001 in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. B-4T2001 in Solid Tumor Drug Details: B4T2-001 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – NTC-801 in Arrhythmias
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - NTC-801 in Arrhythmias report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. NTC-801 in Arrhythmias Drug Details: NTC-801 (BMS-914392) is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – NTC-011 in Otitis Externa
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - NTC-011 in Otitis Externa report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.NTC-011 in Otitis ExternaDrug Details:NTC-011 is under development for the treatment of otitis...
-
Product Insights
NewBacterial Conjunctivitis – Drugs In Development, 2024
Empower your strategies with our Bacterial Conjunctivitis – Drugs In Development, 2024 report and make more profitable business decisions. Bacterial conjunctivitis is an inflammation of the conjunctiva caused by pathogenic bacteria. Bacterial conjunctivitis is usually caused by Staphylococcus aureus, Streptococcus pneumoniae, Haemophilus sp, or, less commonly, Chlamydia trachomatis. Symptoms include redness in the white of the eye or inner eyelid, itchy eyes, blurred vision, increased sensitivity to light, and burning eyes. Treatment includes antibiotics. The Bacterial Conjunctivitis drugs in development market...
-
Product Insights
NewBlepharitis – Drugs In Development, 2024
Empower your strategies with our Blepharitis – Drugs In Development, 2024 report and make more profitable business decisions. Blepharitis is an inflammation of the eyelids, usually caused by an excess growth of bacteria that is ordinarily found on the skin, blockage of the eyelid's oil glands, and occasionally allergies. Blepharitis signs and symptoms include red and watery eyes, itchy eyelids, and sensitivity to light. Treatment includes antibiotics, lubricating eye drops, and steroid eye drops or ointments. The Blepharitis drugs in development...
-
Product Insights
NewOtitis Media – Drugs In Development, 2024
Empower your strategies with our Otitis Media – Drugs In Development, 2024 report and make more profitable business decisions. Otitis media (OM) is any inflammation of the middle ear, the air-filled space behind the eardrum that contains the tiny vibrating bones of the ear. Symptoms include ear pain, difficulty sleeping, loss of balance, fever, headache, and loss of appetite. Risk factors include age, seasonal factors, and exposure to tobacco smoke or high levels of air pollution. Treatment includes antibiotics and antipyrine....
-
Product Insights
NewConjunctivitis – Drugs In Development, 2024
Empower your strategies with our Conjunctivitis – Drugs In Development, 2024 report and make more profitable business decisions. Conjunctivitis, commonly known as "pink eye", refers to inflammation of the conjunctiva, the thin, transparent layer covering the white part of the eye and the inner surface of the eyelids. This condition can be caused by various factors, including infections, allergies, or irritants. Viral conjunctivitis is typically caused by viruses associated with the common cold; it is highly contagious and often spreads through...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – NT-501 in Glaucoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - NT-501 in Glaucoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. NT-501 in Glaucoma Drug Details: NT-501 is under development for the treatment of...